Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma.

Kuo-Chen HungKun-Lin YangGuan-Cheng HuangYu-Fu ChenWen-Teng ChangChia-Chang Chuang

Published in: Pleura and peritoneum (2020)

CRS followed by HIPEC is feasible in patients with HCC-PM and might provide selected patients a chance for local disease control and longer survival. CRS/HIPEC might be considered as a treatment option in highly selected patients, as part of multimodal therapy approaches.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
minimally invasive
squamous cell carcinoma
stem cells
patient reported outcomes
particulate matter
air pollution
acute coronary syndrome
heavy metals
radiation therapy
patient reported